- Home
- INM vs MHH Comparison
INM vs MHH Comparison
Compare INM & MHH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- MHH
- Stock Information
- Founded
- INM 1981
- MHH 1986
- Country
- INM Canada
- MHH United States
- Employees
- INM N/A
- MHH N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- MHH Professional Services
- Sector
- INM Health Care
- MHH Consumer Discretionary
- Exchange
- INM Nasdaq
- MHH Nasdaq
- Market Cap
- INM 3.2M
- MHH N/A
- IPO Year
- INM N/A
- MHH N/A
- Fundamental
- Price
- INM $2.35
- MHH $7.89
- Analyst Decision
- INM
- MHH
- Analyst Count
- INM 0
- MHH 0
- Target Price
- INM N/A
- MHH N/A
- AVG Volume (30 Days)
- INM 46.2K
- MHH 15.0K
- Earning Date
- INM 05-20-2025
- MHH 05-16-2025
- Dividend Yield
- INM N/A
- MHH N/A
- EPS Growth
- INM N/A
- MHH N/A
- EPS
- INM N/A
- MHH 0.28
- Revenue
- INM $4,832,013.00
- MHH $198,943,000.00
- Revenue This Year
- INM N/A
- MHH $1.22
- Revenue Next Year
- INM N/A
- MHH $5.41
- P/E Ratio
- INM N/A
- MHH $27.57
- Revenue Growth
- INM N/A
- MHH N/A
- 52 Week Low
- INM $1.72
- MHH $7.15
- 52 Week High
- INM $15.70
- MHH $16.00
- Technical
- Relative Strength Index (RSI)
- INM 36.01
- MHH 45.75
- Support Level
- INM $2.25
- MHH $7.30
- Resistance Level
- INM $3.20
- MHH $8.38
- Average True Range (ATR)
- INM 0.20
- MHH 0.53
- MACD
- INM -0.07
- MHH 0.14
- Stochastic Oscillator
- INM 10.00
- MHH 52.94
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.